MENU ▼
Read by QxMD icon Read
search
OPEN IN READ APP
JOURNAL ARTICLE

Cost-effectiveness of Extracorporeal Cardiopulmonary Resuscitation after in-hospital cardiac arrest: a Markov decision model

Benjamin Y Gravesteijn, Marc Schluep, Daphne C Voormolen, Anna C van der Burgh, DinĂ­s Dos Reis Miranda, Sanne E Hoeks, Henrik Endeman
Resuscitation 2019 August 29
31473264

BACKGROUND: This study aimed to estimate the cost-effectiveness of extracorporeal cardiopulmonary resuscitation (ECPR) for in-hospital cardiac arrest treatment.

METHODS: A decision tree and Markov model were constructed based on current literature. The model was conditional on age, Charlson Comorbidity Index (CCI) and sex. Three treatment strategies were considered: ECPR for patients with an Age-Combined Charlson Comorbidity Index (ACCI) below different thresholds (2 - 4), ECPR for everyone (EALL), and ECPR for no one (NE). Cost-effectiveness was assessed with costs per quality-of-life adjusted life years (QALY).

MEASUREMENTS AND MAIN RESULTS: Treating eligible patients with an ACCI below 2 points costs 8,394 (95% CI: 4,922 - 14,911) euro per extra QALY per IHCA patient; treating eligible patients with an ACCI below 3 costs 8,825 (95% CI: 5,192 - 15,777) euro per extra QALY per IHCA patient; treating eligible patients with an ACCI below 4 costs 9311 (95% CI: 5,478 - 16,690) euro per extra QALY per IHCA patient; treating every eligible patient with ECPR costs 10818 (95% CI: 6,357 - 19,400) euro per extra QALY per IHCA patient. For WTP thresholds of 0 to 9,500 euro, NE has the highest probability of being the most cost-effective strategy. For WTP thresholds between 9,500 and 12,500, treating eligible patients with an ACCI below 4 has the highest probability of being the most cost-effective strategy. For WTP thresholds of 12,500 or higher, EALL was found to have the highest probability of being the most cost-effective strategy.

CONCLUSIONS: Given that conventional WTP thresholds in Europe and North-America lie between 50,000 - 100,000 euro or U.S. dollars, ECPR can be considered a cost-effective treatment after in-hospital cardiac arrest from a healthcare perspective. More research is necessary to validate the effectiveness of ECPR, with a focus on the long-term effects of complications of ECPR.

Comments

You need to log in or sign up for an account to be able to comment.

No comments yet, be the first to post one!

Related Papers

Available on the App Store

Available on the Play Store
Remove bar
Read by QxMD icon Read
31473264
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"